Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
May 8, 2025
BioUtah president and CEO, Kelvyn Cullmore, recently penned an op-ed published in the Deseret News on the need to fix the Inflation Reduction Act’s (IRA) “pill penalty.” The pill penalty refers to a provision in the IRA that allows Medicare to impose government drug negotiations for small-molecule drugs (like pills and tablets) years sooner than for large-molecule drugs (biologics). Cullilmore notes that there are times when government interventions create unanticipated negative consequences. Such is the case with this IRA policy.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
